United States

Coloplast A/S (COLOb.CO)

COLOb.CO on Copenhagen Stock Exchange

6:54am EST
Change (% chg)

kr.-5.00 (-1.12%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for COLOb.CO


Coloplast A/S is a Denmark-based company active within the healthcare sector. It is engaged in the development, marketing and sale of intimate healthcare products and services, targeting people with diseases of private and personal nature. Its operations are structured into four business areas: Ostomy Care offering products for... (more)


Beta: 0.86
Market Cap(Mil.): kr.88,664.40
Shares Outstanding(Mil.): 198.00
Dividend: 9.00
Yield (%): 3.01


  COLOb.CO Industry Sector
P/E (TTM): 30.23 32.25 29.87
EPS (TTM): 14.81 -- --
ROI: 52.66 13.46 14.95
ROE: 64.31 17.16 16.29

BRIEF-Coloplast reaches milestone in South Korea

* Government of South Korea will be improving subsidies to country's catheter users after turn of year

Nov 29 2016

Coloplast's UK business thrives again, but weak pound hurts -CFO

COPENHAGEN, Nov 2 Coloplast's British operations are thriving again after some difficult years, but the weak pound hurts the bottom line for the Danish healthcare maker, chief financial officer Anders Lonning-Skovgaard said.

Nov 02 2016

BRIEF-Coloplast FY EBIT dented by $112 mln provisions for U.S lawsuit

* Says full-year EBIT was impacted by a provision of 750 million Danish crowns ($111.89 million) to cover potential settlements and costs in connection with lawsuits in the United States

Nov 02 2016

BRIEF-Coloplast Q4 EBIT ex-items DKK 1.28 bln, slightly below expectatons

* Q4 revenue 3.74 billion Danish crowns ($557 million)(Reuters poll 3.80 billion crowns)

Nov 02 2016

BRIEF-Coloplast introduces new wound dressing as part of growth ambition

* Says Coloplast introduces new silicone wound dressings as part of growth ambition.

Sep 26 2016

BRIEF-Kristian Villumsen sells and buys shares in Coloplast

* Kristian Villumsen, Executive Vice President, sold 60,000 shares in Coloplast at 504.08 Danish crowns ($76.24) per share

Sep 07 2016

UPDATE 1-Denmark's Coloplast to invest in UK despite Brexit -CFO

* "It's difficult to predict the outcome of Britain's negotiations with the EU but we will continue to invest in Britain," said Chief Financial Officer Anders Lonning-Skovgaard

Aug 16 2016

BRIEF-Coloplast Q3 EBIT DKK 1.20 billion, below estimates

* Q3 revenue 3.69 billion Danish crowns ($559.15 million) versus 3.72 billion crowns seen in Reuters poll

Aug 16 2016

Coloplast cuts growth forecast due to emerging markets challenges

COPENHAGEN, June 22 Danish healthcare products maker Coloplast on Wednesday adjusted its growth forecast downwards due to a challenging macroeconomic environment in emerging markets.

Jun 22 2016

BRIEF-Coloplast adjusts downwards 3-yr organic revenue growth outlook

* Says Board approved new long-term financial guidance, spanning three years

Jun 22 2016

Earnings vs. Estimates